These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30455372)

  • 1. Camelid single-domain antibodies raised by DNA immunization are potent inhibitors of EGFR signaling.
    Rossotti MA; Henry KA; van Faassen H; Tanha J; Callaghan D; Hussack G; Arbabi-Ghahroudi M; MacKenzie CR
    Biochem J; 2019 Jan; 476(1):39-50. PubMed ID: 30455372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement.
    Henry KA; Nguyen TD; Baral TN; Hussack G; Raphael S; Arbabi-Ghahroudi M; Robert A; Durocher Y; Wu C; Jaramillo ML; MacKenzie CR
    Biochem Biophys Res Commun; 2021 Jul; 562():154-161. PubMed ID: 34058562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Clostridium difficile toxin B with VHH-Fc fusions targeting the delivery and CROPs domains.
    Hussack G; Ryan S; van Faassen H; Rossotti M; MacKenzie CR; Tanha J
    PLoS One; 2018; 13(12):e0208978. PubMed ID: 30540857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-domain antibodies and their utility.
    Baral TN; MacKenzie R; Arbabi Ghahroudi M
    Curr Protoc Immunol; 2013 Nov; 103():2.17.1-2.17.57. PubMed ID: 24510545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of camelid single-domain antibodies against HER2.
    Hussack G; Raphael S; Lowden MJ; Henry KA
    BMC Res Notes; 2018 Dec; 11(1):866. PubMed ID: 30518413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Llama DNA Immunization and Isolation of Functional Single-Domain Antibody Binders.
    Trempe F; Rossotti MA; Maqbool T; MacKenzie CR; Arbabi-Ghahroudi M
    Methods Mol Biol; 2022; 2446():37-70. PubMed ID: 35157268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of TGF-β-neutralizing single-domain antibodies of predetermined epitope specificity using next-generation DNA sequencing.
    Henry KA; Hussack G; Collins C; Zwaagstra JC; Tanha J; MacKenzie CR
    Protein Eng Des Sel; 2016 Oct; 29(10):439-443. PubMed ID: 27613412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Single-Domain Antibodies from Immune Phage Display Libraries.
    Rossotti MA; Trempe F; van Faassen H; Hussack G; Arbabi-Ghahroudi M
    Methods Mol Biol; 2023; 2702():107-147. PubMed ID: 37679618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
    Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC
    PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies.
    Henry KA; Sulea T; van Faassen H; Hussack G; Purisima EO; MacKenzie CR; Arbabi-Ghahroudi M
    PLoS One; 2016; 11(9):e0163113. PubMed ID: 27631624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
    Tintelnot J; Baum N; Schultheiß C; Braig F; Trentmann M; Finter J; Fumey W; Bannas P; Fehse B; Riecken K; Schuetze K; Bokemeyer C; Rösner T; Valerius T; Peipp M; Koch-Nolte F; Binder M
    Mol Cancer Ther; 2019 Apr; 18(4):823-833. PubMed ID: 30824613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
    Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
    Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.
    Nevoltris D; Lombard B; Dupuis E; Mathis G; Chames P; Baty D
    ACS Nano; 2015 Feb; 9(2):1388-99. PubMed ID: 25603171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen recognition by single-domain antibodies: structural latitudes and constraints.
    Henry KA; MacKenzie CR
    MAbs; 2018; 10(6):815-826. PubMed ID: 29916758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VHH characterization.Recombinant VHHs: Production, characterization and affinity.
    Chabrol E; Stojko J; Nicolas A; Botzanowski T; Fould B; Antoine M; Cianférani S; Ferry G; Boutin JA
    Anal Biochem; 2020 Jan; 589():113491. PubMed ID: 31676284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of newly developed anti-bone morphogenetic protein 4 llama-derived antibodies with commercially available BMP4 inhibitors.
    Calpe S; Correia AC; Sancho-Serra Mdel C; Krishnadath KK
    MAbs; 2016; 8(4):678-88. PubMed ID: 26967714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Camelid Single-Domain Antibodies Against Native Proteins Using Recombinant Multivalent Peptide Ligands.
    Alturki NA; Henry KA; MacKenzie CR; Arbabi-Ghahroudi M
    Methods Mol Biol; 2015; 1348():167-89. PubMed ID: 26424272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camelid Single-Domain Antibodies (VHHs) against Crotoxin: A Basis for Developing Modular Building Blocks for the Enhancement of Treatment or Diagnosis of Crotalic Envenoming.
    Luiz MB; Pereira SS; Prado NDR; Gonçalves NR; Kayano AM; Moreira-Dill LS; Sobrinho JC; Zanchi FB; Fuly AL; Fernandes CF; Zuliani JP; Soares AM; Stabeli RG; Fernandes CFC
    Toxins (Basel); 2018 Mar; 10(4):. PubMed ID: 29596324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paper Title "Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody".
    Sharifi J; Khirehgesh MR; Akbari B; Soleymani B; Mansouri K
    Mol Biotechnol; 2021 Jun; 63(6):525-533. PubMed ID: 33772436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect.
    Chen T; Liu X; Hong H; Wei H
    J Transl Med; 2020 Oct; 18(1):376. PubMed ID: 33023595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.